Home> Products> current treatment regimen

{ "products": [ { "_id": "66642d09ccd5ce1a1075bbfe", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "LT PRIDE 25", "description": "LT PRIDE 25\nLevosulpiride (25mg)\nLT Pride 25 contains Levosulpiride (25mg), a medication used primarily to treat psychiatric disorders and gastrointestinal issues. Levosulpiride is a dopamine receptor antagonist that acts on the central and peripheral nervous systems.\n\nIn psychiatric conditions, Levosulpiride is often prescribed for:\n\nDepressive Disorders: It may help improve mood and reduce symptoms of depression.\nAnxiety Disorders: Levosulpiride can be used as an adjunctive treatment to manage anxiety symptoms.\nSchizophrenia and Psychotic Disorders: It may help control symptoms such as hallucinations and delusions.\nIn gastrointestinal conditions, Levosulpiride is used to:\n\nFunctional Dyspepsia: It helps relieve symptoms like bloating, nausea, and early satiety by regulating gastric motility.\nGastroesophageal Reflux Disease (GERD): Levosulpiride can reduce reflux symptoms and improve esophageal motility.\nIrritable Bowel Syndrome (IBS): It may alleviate symptoms such as abdominal pain and altered bowel habits.\nLevosulpiride works by blocking dopamine receptors, which can modulate neurotransmitter levels in the brain and regulate gastrointestinal motility. It is important to take Levosulpiride as prescribed by a healthcare professional, as dosage and duration of treatment vary based on the condition being treated.\n\nCommon side effects of Levosulpiride may include drowsiness, dizziness, gastrointestinal disturbances, and hormonal changes. It is not recommended for use in certain conditions such as Parkinson's disease, pheochromocytoma, or hypersensitivity to the drug.\n\nAlways consult with your doctor before starting or adjusting any medication regimen, as they can provide personalized guidance based on your medical history and current health status.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/lt-pride-25-133776\n\n\n\n\n\n\n", "price": 99.0, "discountamount": 30.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "IBS", "GERD", "Call", "mood", "25mg", "drug", "Email", "brain", "doctor", "dosage", "nausea", "central", "bloating", "WhatsApp", "LT PRIDE", "duration", "delusions", "Parkinson", "dizziness", "drowsiness", "depression", "information", "sterispharma", "bowel habits", "sterisonline", "Levosulpiride", "early satiety", "Schizophrenia", "hallucinations", "abdominal pain", "reflux symptoms", "medical history", "pheochromocytoma", "hypersensitivity", "gastric motility", "anxiety symptoms", "hormonal changes", "Anxiety Disorders", "dopamine receptors", "medication regimen", "Psychotic Disorders", "Common side effects", "esophageal motility", "adjunctive treatment", "Functional Dyspepsia", "Depressive Disorders", "personalized guidance", "psychiatric disorders", "current health status", "psychiatric conditions", "healthcare professional", "neurotransmitter levels", "gastrointestinal issues", "Irritable Bowel Syndrome", "gastrointestinal motility", "peripheral nervous systems", "gastrointestinal conditions", "dopamine receptor antagonist", "gastrointestinal disturbances", "Gastroesophageal Reflux Disease" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1570, "imageuri": "https://productimages.withfloats.com/actual/66642d0b0b1c30627459efc2.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/66642d0b0b1c30627459efc2.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-08T10:06:01.299Z", "updatedon": "2024-06-28T09:30:13.753Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/lt-pride-25/1570", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LT PRIDE 25", "category": "GASTROLOGYRANGE", "tags": [ "LT PRIDE 25", "Levosulpiride (25mg)", "Levosulpiride 25mg in Hindi", "Levosulpiride side effects", "Levosulpiride 25 mg brand name", "Levosulpiride 25 mg Tablet price", "Levosulpiride dose" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6661a57d8da3a81d5c6a17dd", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "MYCOPLASM M 500", "description": "MYCOPLASM M 500\nMycophenolate mofetil (500mg)\nMycoplasm M 500 is a medication containing Mycophenolate Mofetil in a 500mg dose. Mycophenolate Mofetil is an immunosuppressive drug used to prevent rejection in organ transplantation, particularly kidney, heart, and liver transplants. It works by inhibiting the proliferation of T and B lymphocytes, which are involved in the immune response that leads to rejection.\n\nThis medication is typically prescribed in combination with other immunosuppressants as part of a comprehensive transplant treatment regimen. It is important to take Mycoplasm M 500 exactly as prescribed by your healthcare provider to ensure optimal therapeutic outcomes and to minimize the risk of rejection or other complications.\n\nCommon side effects of Mycophenolate Mofetil may include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal pain. It can also increase the risk of infections due to its immunosuppressive effects. Patients should be monitored regularly by their healthcare provider while taking this medication to assess for any potential adverse effects and to adjust the dosage as needed.\n\nMycoplasm M 500 should not be used in pregnant women or those planning to become pregnant without consulting a healthcare professional, as it can cause harm to the developing fetus. Additionally, it may interact with other medications, so it is important to inform your doctor about all the medications you are currently taking before starting Mycoplasm M 500 therapy.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/mycoplasm-m-500-133669\n\n\n\n\n\n\n", "price": 789.0, "discountamount": 237.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "part", "Call", "harm", "risk", "Email", "heart", "ORDER", "nausea", "kidney", "dosage", "doctor", "vomiting", "WhatsApp", "Patients", "diarrhea", "rejection", "infections", "500mg dose", "combination", "information", "sterisonline", "proliferation", "B lymphocytes", "abdominal pain", "pregnant women", "immune response", "developing fetus", "other medications", "liver transplants", "other complications", "healthcare provider", "Common side effects", "organ transplantation", "Mycophenolate mofetil", "immunosuppressive drug", "Mycoplasm M 500 therapy", "healthcare professional", "other immunosuppressants", "immunosuppressive effects", "potential adverse effects", "optimal therapeutic outcomes", "gastrointestinal disturbances", "comprehensive transplant treatment regimen" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1472, "imageuri": "https://productimages.withfloats.com/actual/6661a57fdd39d2ccddbc3bb9.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/6661a57fdd39d2ccddbc3bb9.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T12:03:09.216Z", "updatedon": "2024-06-29T05:30:13Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/mycoplasm-m-500/1472", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MYCOPLASM M 500", "category": "NEPHROLOGYRANGE", "tags": [ "MYCOPLASM M 500", "Mycophenolate mofetil (500mg)", "Mycophenolate mofetil 500 mg tablet", "Mycophenolate mofetil 500 mg price", "Mycophenolate mofetil 500 mg dosage", "Mycophenolate mofetil uses", "Mycophenolate mofetil side effects", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665eff188da3a81d5c69e749", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIDAPA 3D 10/100/1000 SR ", "description": "GLIDAPA 3D 10/100/1000 SR \nDapaflozin 10, Sitagliptin 100 mg & Metformin SR 1000 mg\nIntroduction\nGLIDAPA 3D 10/100/1000 SR is a comprehensive oral medication tailored for the treatment of Type 2 diabetes. This potent combination incorporates Dapagliflozin (10 mg), Sitagliptin (100 mg), and a higher dose of Metformin (1000 mg, sustained release), designed to effectively manage high blood sugar levels throughout the day.\n\nMechanism of Action\n\nDapagliflozin (10 mg): As an SGLT2 inhibitor, Dapagliflozin facilitates the removal of excess glucose from the body via the urine, helping to reduce blood glucose levels and also supporting weight loss and cardiovascular health.\nSitagliptin (100 mg): A DPP-4 inhibitor, Sitagliptin increases the levels of incretin hormones, which enhances the pancreatic response to high blood sugar after meals by increasing insulin production and decreasing glucagon secretion.\nMetformin SR (1000 mg): The higher dose of Metformin in this formulation works to decrease hepatic glucose production, improve insulin sensitivity, and reduce glucose absorption in the intestines. The sustained-release form minimizes gastrointestinal side effects and provides more stable blood sugar control.\nBenefits\nGLIDAPA 3D 10/100/1000 SR offers a potent therapeutic strategy by combining three drugs, each targeting a different aspect of diabetes management. This not only maximizes glucose control but also simplifies the treatment regimen, potentially enhancing patient compliance and reducing the risk of long-term complications.\n\nDosage and Administration\n\nDosage: The dosage should be tailored to the individual’s current health status, effectiveness of the treatment, and tolerability. Regular monitoring of blood glucose and adjustment of the dose may be necessary.\nAdministration: It is recommended to take the medication once daily in the morning, with or without food. The tablet should be swallowed whole to ensure proper release of Metformin over time.\nSide Effects\nCommon side effects may include urinary tract infections (due to Dapagliflozin), potential gastrointestinal disturbances such as nausea or diarrhea (common with Metformin), and a sore throat or nasopharyngitis associated with Sitagliptin. These side effects are generally mild and manageable.\n\nConclusion\nGLIDAPA 3D 10/100/1000 SR is a highly effective option for managing Type 2 diabetes, offering a strategic blend of three medications to control blood sugar levels, improve metabolic health, and reduce the risk of diabetes-related complications. This enhanced formulation is suitable for patients requiring a robust approach to diabetes management, emphasizing the importance of ongoing collaboration with healthcare providers to tailor and optimize treatment.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/glidapa-3d-10-100-1000-sr-134216\n\n\n\n\n\n", "price": 595.0, "discountamount": 178.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "time", "food", "body", "risk", "meals", "Order", "EMAIL", "urine", "nausea", "tablet", "Action", "morning", "1000 mg", "removal", "patients", "Benefits", "diarrhea", "Mechanism", "Conclusion", "Dapaflozin", "intestines", "adjustment", "importance", "individual", "weight loss", "Sitagliptin", "higher dose", "three drugs", "information", "sore throat", "tolerability", "Introduction", "sterisonline", "sterispharma", "Metformin SR", "Dapagliflozin", "CALL/WHATSAPP", "effectiveness", "proper release", "excess glucose", "SGLT2 inhibitor", "Type 2 diabetes", "robust approach", "DPP-4 inhibitor", "strategic blend", "nasopharyngitis", "glucose control", "metabolic health", "different aspect", "effective option", "sustained release", "treatment regimen", "incretin hormones", "three medications", "glucagon secretion", "Regular monitoring", "patient compliance", "glucose absorption", "insulin production", "potent combination", "pancreatic response", "diabetes management", "insulin sensitivity", "Common side effects", "enhanced formulation", "healthcare providers", "blood glucose levels", "ongoing collaboration", "cardiovascular health", "Administration Dosage", "current health status", "sustained-release form", "high blood sugar levels", "long-term complications", "urinary tract infections", "GLIDAPA 3D 10/100/1000 SR", "stable blood sugar control", "hepatic glucose production", "potent therapeutic strategy", "gastrointestinal side effects", "comprehensive oral medication", "diabetes-related complications", "potential gastrointestinal disturbances" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1303, "imageuri": "https://productimages.withfloats.com/actual/665eff1a8e77bb2c7151ebf4.png", "tileimageuri": "https://productimages.withfloats.com/tile/665eff1a8e77bb2c7151ebf4.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T11:48:40.052Z", "updatedon": "2024-06-04T11:48:40.052Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glidapa-3d-10-100-1000-sr-/1303", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIDAPA 3D 10/100/1000 SR ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665efdbd66170d1ff8cb13bf", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIDAPA 3D 10/100/500 SR ", "description": "GLIDAPA 3D 10/100/500 SR \nDapaflozin 10 mg, Sitagliptin 100 mg & Metformin SR 500 mg\nIntroduction\nGLIDAPA 3D 10/100/500 SR is a sophisticated, multi-mechanism oral medication designed for the management of Type 2 diabetes. It combines Dapagliflozin (10 mg), Sitagliptin (100 mg), and Metformin (500 mg, sustained release), offering a robust, integrated approach to controlling high blood glucose levels.\n\nMechanism of Action\n\nDapagliflozin (10 mg): As an SGLT2 inhibitor, Dapagliflozin promotes the excretion of glucose through urine by blocking its reabsorption in the kidneys. This helps to lower blood sugar levels and also has benefits for weight loss and cardiovascular health.\nSitagliptin (100 mg): A DPP-4 inhibitor, Sitagliptin works by enhancing the body's own ability to lower blood glucose levels in response to meals. It does this by increasing the levels of incretin hormones, which affect the pancreas to produce more insulin and less glucagon.\nMetformin SR (500 mg): Metformin works primarily by reducing glucose production in the liver, improving insulin sensitivity, and lowering glucose absorption in the gut. The sustained-release (SR) formulation ensures a steady release over time, minimizing gastrointestinal side effects and maintaining more consistent blood sugar control.\nBenefits\nGLIDAPA 3D 10/100/500 SR provides a comprehensive treatment solution by addressing several key pathways in glucose metabolism, thereby reducing the risk of both hyperglycemia and associated complications. The combination of these three active substances in a single formulation enhances convenience and potentially improves adherence to treatment protocols.\n\nDosage and Administration\n\nDosage: The recommended starting dose depends on the patient’s current treatment regimen and their specific health profile. Adjustments should be made based on effectiveness and tolerability, under the guidance of a healthcare professional.\nAdministration: This medication should be taken once daily in the morning, with or without food. The tablet should be swallowed whole to maintain the sustained release of Metformin.\nSide Effects\nPossible side effects of GLIDAPA 3D 10/100/500 SR include urinary tract and genital infections (due to Dapagliflozin), nausea or a sore throat (from Sitagliptin), and digestive issues such as diarrhea or abdominal pain (common with Metformin). Most side effects are manageable and tend to decrease over time.\n\nConclusion\nGLIDAPA 3D 10/100/500 SR is a versatile and effective option for those managing Type 2 diabetes, offering triple-action treatment in one convenient medication. It targets various aspects of diabetes management, improves glycemic control, and enhances overall quality of life. Patients are advised to maintain regular follow-ups with their healthcare provider to optimize treatment outcomes and manage any side effects.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/glidapa-3d-10-100-500-sr-134215", "price": 575.0, "discountamount": 172.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "gut", "time", "life", "risk", "food", "body", "urine", "liver", "EMAIL", "Order", "meals", "500 mg", "nausea", "tablet", "patient", "ability", "kidneys", "morning", "response", "diarrhea", "pancreas", "guidance", "benefits", "adherence", "versatile", "excretion", "Conclusion", "sore throat", "Sitagliptin", "weight loss", "Adjustments", "combination", "information", "convenience", "Introduction", "sterispharma", "Metformin SR", "reabsorption", "sterisonline", "urinary tract", "CALL/WHATSAPP", "hyperglycemia", "Dapagliflozin", "less glucagon", "effectiveness", "starting dose", "abdominal pain", "steady release", "overall quality", "SGLT2 inhibitor", "various aspects", "Type 2 diabetes", "DPP-4 inhibitor", "Dapaflozin 10 mg", "effective option", "digestive issues", "glycemic control", "Most side effects", "sustained release", "incretin hormones", "regular follow-ups", "genital infections", "blood sugar levels", "glucose metabolism", "glucose absorption", "glucose production", "treatment outcomes", "single formulation", "diabetes management", "insulin sensitivity", "healthcare provider", "treatment protocols", "several key pathways", "Administration Dosage", "Possible side effects", "cardiovascular health", "triple-action treatment", "specific health profile", "three active substances", "healthcare professional", "associated complications", "GLIDAPA 3D 10/100/500 SR", "current treatment regimen", "one convenient medication", "high blood glucose levels", "robust, integrated approach", "gastrointestinal side effects", "consistent blood sugar control", "comprehensive treatment solution", "sustained-release (SR) formulation", "sophisticated, multi-mechanism oral medication" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1300, "imageuri": "https://productimages.withfloats.com/actual/665efdc0e874b19df8b5f4ce.png", "tileimageuri": "https://productimages.withfloats.com/tile/665efdc0e874b19df8b5f4ce.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T11:42:53.803Z", "updatedon": "2024-06-04T11:42:53.803Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glidapa-3d-10-100-500-sr-/1300", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIDAPA 3D 10/100/500 SR ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665ef948161afa2274ff25b9", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLICLAGALZE MR 60 ", "description": "GLICLAGALZE MR 60 \nGliclazide SR 60 mg\nIntroduction\nGLICLAGALZE MR 60 is an oral medication tailored for the treatment of Type 2 diabetes, featuring a 60 mg dose of Gliclazide in a sustained release (SR) formulation. This medication is designed to offer consistent control of blood sugar levels throughout the day, minimizing fluctuations and improving overall diabetes management.\n\nMechanism of Action\n\nGliclazide SR (60 mg): Gliclazide is a member of the sulfonylurea class of diabetes medications. It operates by stimulating the pancreatic beta cells to produce more insulin, a key hormone that helps lower blood glucose. The SR formulation allows for a gradual release of Gliclazide, maintaining a steady level of the drug in the bloodstream, which helps to prevent the peaks and troughs in blood sugar levels that can be problematic in diabetes management.\nBenefits\nGLICLAGALZE MR 60 is particularly beneficial for patients who need a moderate increase in their insulin production but are concerned about the risks of hypoglycemia associated with other diabetes treatments. The sustained release formulation ensures a more uniform effect over the day, which can lead to better adherence to treatment and overall patient satisfaction.\n\nDosage and Administration\n\nDosage: The dosage should be individualized based on the patient’s current treatment regimen, effectiveness, and tolerability. It is crucial to monitor blood glucose levels regularly to ensure optimal control and to adjust the dosage as needed.\nAdministration: This medication should be taken with food, ideally with the first main meal of the day. The tablet must be swallowed whole to maintain the integrity of the sustained release mechanism and ensure effective drug delivery.\nSide Effects\nCommon side effects of GLICLAGALZE MR 60 may include gastrointestinal disturbances such as nausea and upset stomach. There is also a risk of hypoglycemia, particularly if meals are skipped or delayed, or when combined with other glucose-lowering medications.\n\nConclusion\nGLICLAGALZE MR 60 offers a reliable and effective approach for managing Type 2 diabetes, providing a balanced and prolonged action to stabilize blood glucose levels. It supports a comprehensive diabetes management plan, which should include regular physical activity, diet modification, and routine monitoring of blood glucose. As with any medication regimen, it is important to consult with a healthcare provider to adjust the treatment according to individual health needs and response to therapy.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/gliclagalze-mr-60-133418\n\n\n\n\n\n", "price": 128.0, "discountamount": 38.4, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "food", "peaks", "risks", "upset", "meals", "Order", "EMAIL", "member", "nausea", "tablet", "stomach", "therapy", "troughs", "reliable", "response", "balanced", "Benefits", "patients", "integrity", "adherence", "60 mg dose", "Conclusion", "key hormone", "bloodstream", "information", "tolerability", "Introduction", "fluctuations", "sterispharma", "hypoglycemia", "sterisonline", "steady level", "effectiveness", "Gliclazide SR", "CALL/WHATSAPP", "uniform effect", "GLICLAGALZE MR", "SR formulation", "gradual release", "optimal control", "Type 2 diabetes", "oral medication", "first main meal", "prolonged action", "diet modification", "moderate increase", "blood sugar levels", "sulfonylurea class", "consistent control", "effective approach", "insulin production", "routine monitoring", "medication regimen", "Common side effects", "healthcare provider", "blood glucose levels", "diabetes medications", "pancreatic beta cells", "Administration Dosage", "effective drug delivery", "individual health needs", "current treatment regimen", "other diabetes treatments", "regular physical activity", "overall diabetes management", "sustained release mechanism", "overall patient satisfaction", "sustained release formulation", "gastrointestinal disturbances", "other glucose-lowering medications", "comprehensive diabetes management plan" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1293, "imageuri": "https://productimages.withfloats.com/actual/665ef94b480b81124f8647ec.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/665ef94b480b81124f8647ec.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T11:23:52.299Z", "updatedon": "2024-06-04T11:23:52.299Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/gliclagalze-mr-60-/1293", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLICLAGALZE MR 60 ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665ef6a3161afa2274ff2581", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLICLAGLAZE MET ", "description": "GLICLAGLAZE MET \ngliclazide SR (60mg),Metformin SR (500 mg)\nIntroduction\nGLICLAGLAZE MET is an advanced formulation designed for the effective management of Type 2 diabetes. This oral medication combines sustained release (SR) forms of Gliclazide (60 mg) and Metformin (500 mg), offering controlled and consistent blood glucose control throughout the day.\n\nMechanism of Action\n\nGliclazide SR (60 mg): As a sulfonylurea drug, Gliclazide SR works by stimulating insulin secretion from the beta cells of the pancreas. The sustained release form provides a gradual increase in insulin levels, reducing the risk of sudden drops in blood sugar that can lead to hypoglycemia.\nMetformin SR (500 mg): Metformin SR decreases hepatic glucose production and increases insulin sensitivity in peripheral tissues, notably muscles. Its sustained release formulation ensures a steady effect on blood sugar levels, improving metabolic response without the peaks and troughs associated with immediate-release forms.\nBenefits\nGLICLAGLAZE MET is specifically tailored to provide a more stable and prolonged effect in controlling blood sugar, which can enhance patient compliance and comfort. The combination of Gliclazide SR and Metformin SR in one tablet simplifies the treatment regimen, potentially improving adherence and reducing the risk of missed doses.\n\nDosage and Administration\n\nDosage: The dosage of GLICLAGLAZE MET should be individualized based on the patient's current control and therapeutic response. It is crucial to monitor blood glucose regularly to adjust the dosage appropriately.\nAdministration: This medication should be taken with meals to minimize gastrointestinal side effects and improve the absorption of the drug.\nSide Effects\nWhile GLICLAGLAZE MET is generally well tolerated, some patients may experience side effects such as gastrointestinal discomfort, including nausea and diarrhea. The risk of hypoglycemia is present but is generally lower with the sustained release formulation.\n\nConclusion\nGLICLAGLAZE MET offers a balanced and effective approach to managing Type 2 diabetes by combining two proven diabetes medications in a sustained release form. This regimen not only aids in maintaining steady blood glucose levels but also supports overall diabetes management by enhancing patient adherence to treatment. Patients are encouraged to maintain a dialogue with their healthcare provider to optimize treatment outcomes and address any concerns during their treatment journey.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/gliclaglaze-met-133421\n\n\n\n\n\n", "price": 149.0, "discountamount": 44.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "mg", "day", "risk", "Order", "EMAIL", "peaks", "doses", "meals", "stable", "Action", "nausea", "muscles", "troughs", "Benefits", "pancreas", "diarrhea", "balanced", "dialogue", "concerns", "patients", "SR) forms", "Mechanism", "beta cells", "Conclusion", "one tablet", "controlled", "absorption", "combination", "information", "Metformin SR", "sudden drops", "hypoglycemia", "Introduction", "sterispharma", "sterisonline", "steady effect", "CALL/WHATSAPP", "gliclazide SR", "insulin levels", "oral medication", "current control", "Type 2 diabetes", "GLICLAGLAZE MET", "gradual increase", "prolonged effect", "insulin secretion", "patient adherence", "treatment journey", "treatment regimen", "sulfonylurea drug", "effective approach", "blood sugar levels", "metabolic response", "peripheral tissues", "patient compliance", "treatment outcomes", "healthcare provider", "insulin sensitivity", "advanced formulation", "effective management", "therapeutic response", "Administration Dosage", "sustained release form", "immediate-release forms", "hepatic glucose production", "overall diabetes management", "steady blood glucose levels", "gastrointestinal discomfort", "gastrointestinal side effects", "two proven diabetes medications", "consistent blood glucose control" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1289, "imageuri": "https://productimages.withfloats.com/actual/665ef6a67b1fc3f9dd48259d.png", "tileimageuri": "https://productimages.withfloats.com/tile/665ef6a67b1fc3f9dd48259d.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T11:12:35.652Z", "updatedon": "2024-06-04T11:12:35.652Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/gliclaglaze-met-/1289", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLICLAGLAZE MET ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665ef17474d94b15a06c31e2", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLICLAGLAZE M 40 ", "description": "GLICLAGLAZE M 40 \ngliclazide (40mg),Metformin (500 mg)\nIntroduction\nGLICLAGLAZE M 40 is a combination medication designed to manage blood sugar levels in individuals with Type 2 diabetes. This oral treatment integrates two potent antidiabetic agents: Gliclazide (40 mg) and Metformin (500 mg), each playing a crucial role in diabetes control.\n\nHow It Works\n\nGliclazide (40 mg): As a sulfonylurea, Gliclazide works by stimulating the release of insulin from the pancreatic beta cells. Insulin is the hormone responsible for reducing blood glucose levels. Gliclazide also enhances the sensitivity of peripheral tissues to insulin and reduces the likelihood of clot formation, which is a common complication in diabetes patients.\nMetformin (500 mg): Metformin acts primarily by reducing glucose production in the liver. It also improves insulin sensitivity, enhancing peripheral glucose uptake and utilization. Unlike many other antidiabetic medications, Metformin does not cause hypoglycemia (low blood sugar) and is often associated with weight loss.\nBenefits\nThe dual mechanism of GLICLAGLAZE M 40 offers a comprehensive approach to diabetes management by not only improving insulin production and sensitivity but also addressing the hepatic release of glucose. This combination reduces blood sugar levels effectively while minimizing the risk of side effects common to other diabetes treatments, such as hypoglycemia.\n\nUsage Guidelines\n\nDosage: Typically, the initial dosage is guided by the patient’s current treatment regimen, effectiveness, and tolerability. Adjustment in dosage should be made based on the patient’s blood glucose response, under the supervision of a healthcare provider.\nAdministration: GLICLAGLAZE M 40 should be taken with meals to reduce gastrointestinal side effects and to enhance absorption.\nSide Effects\nWhile GLICLAGLAZE M 40 is generally well-tolerated, it may cause some side effects. Common ones include gastrointestinal disturbances such as nausea and diarrhea, which are often transient. Hypoglycemia may occur, but it is less frequent due to the mitigating action of Metformin.\n\nConclusion\nGLICLAGLAZE M 40 is a cornerstone in the pharmacological treatment of Type 2 diabetes, offering benefits derived from the combined effects of Gliclazide and Metformin. It is essential for patients to follow their healthcare provider’s instructions and to maintain regular check-ups to optimize treatment outcomes and prevent complications. This medication enables patients to manage their diabetes more effectively and improve their quality of life.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/gliclaglaze-m-40-133419\n\n\n\n\n\n\n\n", "price": 149.0, "discountamount": 44.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "life", "risk", "liver", "meals", "40 mg", "Order", "EMAIL", "500 mg", "nausea", "quality", "hormone", "diarrhea", "Benefits", "Metformin", "gliclazide", "Adjustment", "likelihood", "Conclusion", "absorption", "utilization", "cornerstone", "information", "supervision", "individuals", "weight loss", "sulfonylurea", "hypoglycemia", "Introduction", "tolerability", "sterisonline", "instructions", "sterispharma", "crucial role", "complications", "GLICLAGLAZE M", "CALL/WHATSAPP", "effectiveness", "oral treatment", "dual mechanism", "clot formation", "Administration", "initial dosage", "Type 2 diabetes", "hepatic release", "low blood sugar", "diabetes control", "combined effects", "mitigating action", "diabetes patients", "regular check-ups", "blood sugar levels", "treatment outcomes", "peripheral tissues", "glucose production", "insulin production", "diabetes management", "insulin sensitivity", "common complication", "healthcare provider", "blood glucose levels", "pancreatic beta cells", "combination medication", "blood glucose response", "comprehensive approach", "Usage Guidelines Dosage", "pharmacological treatment", "peripheral glucose uptake", "current treatment regimen", "other diabetes treatments", "gastrointestinal disturbances", "gastrointestinal side effects", "two potent antidiabetic agents", "many other antidiabetic medications" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1284, "imageuri": "https://productimages.withfloats.com/actual/665ef175c06ee12d88caa810.png", "tileimageuri": "https://productimages.withfloats.com/tile/665ef175c06ee12d88caa810.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T10:50:28.577Z", "updatedon": "2024-06-04T10:50:28.577Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/gliclaglaze-m-40-/1284", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLICLAGLAZE M 40 ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68c29ba02244c906e7790e2b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TELAVINCE 300", "description": "TELAVINCE 300 is a high-quality antiviral medication containing Tenofovir Disoproxil Fumarate 300 mg, specifically formulated for the effective management of HIV-1 infection and chronic Hepatitis B in adults and adolescents. Manufactured under strict pharmaceutical standards, TELAVINCE 300 offers consistent, potent, and clinically proven antiviral action, helping to suppress viral replication and improve immune function.\n\nTenofovir Disoproxil Fumarate is a nucleotide reverse transcriptase inhibitor (NtRTI). It works by interfering with the enzyme reverse transcriptase, which is essential for viral replication in HIV and Hepatitis B viruses. By inhibiting this enzyme, TELAVINCE 300 reduces the amount of virus in the body, helping to prevent further immune system damage and liver complications.\n\n \nKey Indications:\n \n\nTELAVINCE 300 is indicated for:\n\nHIV-1 Infection: In combination with other antiretroviral agents for the treatment of HIV-1 in adults and adolescents (aged 12 years and older, weighing at least 35 kg).\n\nChronic Hepatitis B: For the treatment of chronic hepatitis B virus infection in adults and adolescents with compensated liver disease and evidence of active viral replication.\n\n \nMechanism of Action:\n \nTenofovir Disoproxil Fumarate is a prodrug of tenofovir, which, once absorbed and metabolized in the body, is converted into tenofovir diphosphate, the active form. Tenofovir diphosphate acts as a competitive inhibitor of reverse transcriptase, incorporating itself into the viral DNA chain and causing premature chain termination. This process disrupts the life cycle of the virus, significantly reducing its ability to multiply and spread.\n\n \nDosage and Administration:\n \n\nRecommended Dose for Adults and Adolescents (≥12 years, ≥35 kg): One tablet (300 mg) once daily, preferably with food.\n\nFor HIV Treatment: Administer in combination with other antiretroviral medications as per the treatment regimen.\n\nFor Chronic Hepatitis B: Monotherapy or as part of combination therapy, depending on patient condition and physician's assessment.\n\nDosage adjustments may be required in patients with renal impairment. Close monitoring is recommended for patients with existing kidney disease.\n\n \nKey Benefits of TELAVINCE 300:\n \n\nPotent Antiviral Action: Rapid and sustained suppression of HIV and HBV replication.\nOnce-Daily Dosing: Improves patient compliance and treatment adherence.\n\nBacked by Clinical Research: Proven efficacy in managing viral load and improving immune markers (CD4 count).\n\nTrusted Quality: Manufactured under GMP-certified facilities with stringent quality control processes.\n\nPart of First-Line Therapy: Recommended in various national and international treatment guidelines for HIV and Hepatitis B.\n\n \nSafety and Precautions:\n \n\nRenal Monitoring: Tenofovir may affect kidney function. Routine renal function tests are recommended before and during treatment.\n\nBone Mineral Density: Long-term use may reduce bone mineral density. Consider monitoring in patients at risk of osteopenia or osteoporosis.\n\nHepatic Flare: Discontinuation of therapy in hepatitis B patients may result in severe acute exacerbations. Liver function should be closely monitored post-treatment.\n\nLactic Acidosis and Hepatomegaly: Rare but serious side effects. Patients presenting symptoms such as abdominal pain, fatigue, or difficulty breathing should seek immediate medical attention.\n\n \n\nPossible Side Effects:\n \n\nMost patients tolerate TELAVINCE 300 well. However, some may experience:\n\nNausea\n\nDiarrhea\n\nHeadache\n\nFatigue\n\nRash\n\nDizziness\n\nDecreased bone mineral density\n\nRenal impairment (in rare cases)\n\nIf any side effects persist or worsen, consult a healthcare professional immediately.\n\n \nStorage Instructions:\n \n\nStore in a cool, dry place below 30°C.\n\nProtect from light and moisture.\n\nKeep out of reach of children.\n\n \n\nWhy Choose TELAVINCE 300?\n \n\nTELAVINCE 300 offers a dependable, clinically validated solution for the long-term management of HIV and Hepatitis B. With its once-daily dosing and proven effectiveness, TELAVINCE 300 is an ideal choice for patients and healthcare providers looking for quality, safety, and therapeutic reliability. It is manufactured by a trusted name in healthcare, ensuring every tablet meets global pharmaceutical standards.\n\n \nDisclaimer:\n \n\nThis product description is for informational purposes only and is not a substitute for professional medical advice. Always consult your doctor or healthcare provider before starting any medication.", "price": 1480.0, "discountamount": 444.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2179, "imageuri": "https://productimages.withfloats.com/actual/68c29ba3794abb27ab248d73.png", "tileimageuri": "https://productimages.withfloats.com/tile/68c29ba3794abb27ab248d73.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-11T09:51:28.508Z", "updatedon": "2025-09-11T09:51:28.508Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/telavince-300/2179", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Tenofovir Disoproxil Fumarate Tablets ip 300 mg", "category": "GENERAL RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68bc22e83c3803d861d696a9", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "CEPHODOXIAA 200", "description": "CEPHODOXIAA 200 is a broad-spectrum oral antibiotic from Steris Healthcare Pvt. Ltd., containing Cefpodoxime Proxetil 200 mg. It belongs to the third-generation cephalosporin class, designed to combat a wide range of bacterial infections effectively. With its high bioavailability, safety profile, and proven efficacy, it is trusted in clinical practice for managing both respiratory and urinary tract infections.\n\nUsage and Benefits\nCEPHODOXIAA 200 is prescribed for the treatment of bacterial infections caused by susceptible microorganisms, including:\n\nRespiratory tract infections (bronchitis, pneumonia, sinusitis, pharyngitis, tonsillitis)\n\nUrinary tract infections (cystitis, pyelonephritis)\n\nEar infections (otitis media)\n\nSkin and soft tissue infections\n\nCertain sexually transmitted infections (like gonorrhea)\n\nCommunity-acquired infections where cephalosporins are indicated\n\nBenefits:\n\nBroad-spectrum antibacterial activity against gram-positive and gram-negative organisms\n\nHigh tolerability and oral bioavailability\n\nConvenient twice-daily dosing\n\nEffective alternative when resistance to other antibiotics is suspected\n\nDosage and Administration\nAdults: Typical dose is 200 mg every 12 hours, depending on the severity of the infection.\n\nChildren: Dose is weight-adjusted, usually prescribed in suspension form.\n\nDuration: Treatment typically lasts 5–14 days depending on the infection type and clinical response.\n\nAdministration Tips:\n\nTake with food to enhance absorption.\n\nComplete the full course even if symptoms improve early.\n\nDo not double the dose if a dose is missed—take it as soon as remembered unless it is nearly time for the next dose.\n\nSide Effects\nLike all medicines, CEPHODOXIAA 200 may cause mild to moderate side effects. Common ones include:\n\nGastrointestinal upset (nausea, diarrhea, abdominal pain)\n\nHeadache or dizziness\n\nSkin rash or itching\n\nRare but serious side effects:\n\nSevere allergic reactions (swelling, difficulty breathing)\n\nPseudomembranous colitis (persistent diarrhea)\n\nLiver enzyme elevations\n\nDrug Interactions\nAntacids & H2 blockers: May reduce absorption of Cefpodoxime. Take at least 2–3 hours apart.\n\nBlood thinners (e.g., warfarin): May increase risk of bleeding.\n\nOther antibiotics: Avoid concurrent use unless directed by a doctor to prevent resistance.\n\nAlways inform your physician of all medications and supplements you are taking before starting therapy.\n\nConclusion\nCEPHODOXIAA 200 (Cefpodoxime Proxetil 200 mg) from Steris Healthcare Pvt. Ltd. is a reliable, broad-spectrum antibiotic used in the management of common bacterial infections. With its excellent safety profile, ease of oral administration, and clinical efficacy, it remains a preferred choice for doctors worldwide. Patients should adhere strictly to prescribed dosage and complete the treatment course to ensure optimal results and prevent antibiotic resistance.", "price": 185.0, "discountamount": 54.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2173, "imageuri": "https://productimages.withfloats.com/actual/68bc22f9fc1a4c6e66f328c5.png", "tileimageuri": "https://productimages.withfloats.com/tile/68bc22f9fc1a4c6e66f328c5.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-06T12:02:48.098Z", "updatedon": "2025-09-08T10:03:20.923Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/cephodoxiaa-200/2173", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Cefpodoxime Proxetil Tablets IP 200 mg", "category": "GENERAL RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }